ALZHEIMER'S DISEASE RESEARCH CENTER
阿尔茨海默病研究中心
基本信息
- 批准号:3104718
- 负责人:
- 金额:$ 172.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1984
- 资助国家:美国
- 起止时间:1984-09-28 至 1994-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This proposal is for a five-year renewal of the Alzheimer's Disease
Research Center at the University of California at San Diego (UCSD) in
consortium with the Salk Institute. The major objective of our ADRC is to
enhance research into Alzheimer's disease (AD), a disorder which is a major
disabling disease of the elderly accounting for half of nursing home
admissions as well as increasing mortality rate and impacting severely upon
families and caregivers. We have sought to enlist investigators and develop
resources necessary to move forward in a significant way in the
understanding of the pathogenesis and pathophysiology of AD with the
ultimate goal of learning enough about the disease to be able to prevent or
alter its clinical course, at the same time improving our understanding of
the clinical diagnosis, course and the relationship of neuropsychological
dysfunction to specific brain lesions. The ADRC provides a clinical and
neuropathological resource based upon annual evaluations of a cohort of
volunteers willing to participate in clinical research, subjects with
Alzheimer's disease and related disorders and normal aged matched
volunteers. The Clinical Core activity provides subjects for research and
pilot projects and also permits study of clinical and neuropsychological
changes during the course of AD; forms the base for development of cross-
cultural studies of AD, specifically, Hispanic, Chinese and Finnish
studies; enables participation in multicenter drug studies and national
registries such as CERAD and THA; generates a well edited longitudinal data
base. The Neuropathological Core provides a source of brain tissue of
patients characterized clinically and neuropathologically for use in
research projects. The ADRC provides a setting to facilitate research
training of AD investigators and information transfer to the professional
and lay communities through our mini-residency program, conferences and
other educational activities. We foster interdisciplinary research
activities through collaborations, seminars, feasibility and pilot
projects. Our specific research projects in this renewal include
investigations of the precursor protein for the Beta amyloid present in
neuritic plaques (Research Project 1); the specific nature of the memory
and other cognitive deficits in the Alzheimer process (Research Project 2);
the quantitative anatomical study of Alzheimer brain in regard to neuronal
populations in dementia (Research Project 3); and the effect of nerve
growth factor as a potential therapeutic modality (Research Project 4); The
UCSD ADRC fosters new research initiatives through pilot and feasibility
projects which span disciplines from electronmicroscopy to
electrophysiology, from clinical psychiatry to neuro-ophthalmology and
which involve faculty at neighboring institutions in San Diego as well as
at UCSD.
该建议是针对阿尔茨海默氏病的五年续约
加州大学圣地亚哥分校(UCSD)的研究中心
萨尔克研究所的财团。我们ADRC的主要目标是
加强对阿尔茨海默氏病(AD)的研究,这是一种主要的疾病
致残的老年人疾病疗养院一半
入院以及增加死亡率并严重影响
家庭和照顾者。我们试图参与调查人员并发展
以重大方式前进所必需的资源
了解AD的发病机理和病理生理学
对疾病的学习足够的最终目标,能够预防或
改变其临床过程,同时提高我们对
神经心理学的临床诊断,过程和关系
特定脑病变功能障碍。 ADRC提供了临床和
基于对同类的年度评估的神经病理资源
愿意参加临床研究的志愿者
阿尔茨海默氏病和相关疾病和正常老年匹配
志愿者。临床核心活动为研究提供了主题和
试点项目,还允许研究临床和神经心理学
广告过程中的变化;构成了跨界发展的基础
广告的文化研究,特别是西班牙裔,中国和芬兰语
研究;使参与多中心药物研究和国家
Cerad和Tha等登记处;生成良好编辑的纵向数据
根据。神经病理核心提供了脑组织的来源
患者在临床和神经病理学上的特征在于
研究项目。 ADRC提供了促进研究的设置
培训广告调查人员和信息转移给专业人士
并通过我们的迷你居住计划,会议和
其他教育活动。我们培养跨学科研究
通过合作,研讨会,可行性和飞行员的活动
项目。我们在此续签中的特定研究项目包括
研究存在于β淀粉样蛋白的前体蛋白
神经斑块(研究项目1);记忆的特定本质
以及阿尔茨海默氏症过程中的其他认知缺陷(研究项目2);
关于神经元的阿尔茨海默氏症大脑的定量解剖学研究
痴呆症的人群(研究项目3);和神经的影响
生长因子是一种潜在的治疗方式(研究项目4);这
UCSD ADRC通过飞行员和可行性促进了新的研究计划
从电子显微镜到跨越学科的项目
电生理学,从临床精神病学到神经浏览学和
涉及圣地亚哥邻近机构的教师以及
在UCSD。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(8)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT KATZMAN其他文献
ROBERT KATZMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT KATZMAN', 18)}}的其他基金
相似国自然基金
煤炭资源与安全开采国家重点实验室“煤炭造福人类,绿色引领未来”主题科普活动
- 批准号:
- 批准年份:2020
- 资助金额:17 万元
- 项目类别:专项基金项目
面向活动类型挖掘和主题提取的人类行为模式研究
- 批准号:41801378
- 批准年份:2018
- 资助金额:25.2 万元
- 项目类别:青年科学基金项目
相似海外基金
The Role of Dopamine in Cognitive Resilience to Alzheimer's Disease Pathology in Healthy Older Adults
多巴胺在健康老年人阿尔茨海默氏病病理认知弹性中的作用
- 批准号:
10678125 - 财政年份:2023
- 资助金额:
$ 172.51万 - 项目类别:
Joint Estimate Diffusion Imaging (JEDI) for improved Tissue Characterization and Neural Connectivity in Aging and Alzheimer's Disease
联合估计扩散成像 (JEDI) 可改善衰老和阿尔茨海默病的组织表征和神经连接
- 批准号:
10662911 - 财政年份:2023
- 资助金额:
$ 172.51万 - 项目类别:
Dark GPCR signaling underlying the Microbiome-Gut-Brain Axis for Alzheimer's Disease and Related Dementia
阿尔茨海默病和相关痴呆症微生物组-肠-脑轴的暗 GPCR 信号传导
- 批准号:
10719150 - 财政年份:2023
- 资助金额:
$ 172.51万 - 项目类别:
Molecular Markers of Cerebrovascular Pathologies in Alzheimer's Disease and Related Dementias
阿尔茨海默病和相关痴呆症脑血管病理学的分子标志物
- 批准号:
10806855 - 财政年份:2023
- 资助金额:
$ 172.51万 - 项目类别:
Recruitment and Retention for Alzheimer's Disease Diversity Genetic Cohorts in the ADSP (READD-ADSP)
ADSP 中阿尔茨海默病多样性遗传群体的招募和保留 (READD-ADSP)
- 批准号:
10654529 - 财政年份:2022
- 资助金额:
$ 172.51万 - 项目类别: